Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia
- 25 August 2005
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 80 (2-3) , 315-322
- https://doi.org/10.1016/j.schres.2005.07.013
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Psychotropic Effects of COX-2 Inhibitors - A Possible New Approach for the Treatment of Psychiatric DisordersPharmacopsychiatry, 2004
- Prostaglandin-mediated control of rat brain kynurenic acid synthesis – opposite actions by COX-1 and COX-2 isoformsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acidActa Physiologica Scandinavica, 2002
- Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New EvidenceAnnual Review of Pharmacology and Toxicology, 2001
- Kynurenine metabolism in Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Increased kynurenic acid levels and decreased brain kynurenine aminotransferasei in patients with down syndromeLife Sciences, 1996
- Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic StrokeStroke, 1995
- Phencyclidine and the midbrain dopamine system: Electrophysiology and behaviorNeurotoxicology and Teratology, 1994
- Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic SchizophrenicsThe British Journal of Psychiatry, 1969
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963